NCT02608970 Safety and Tolerability Study of BMS-986177 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02608099 Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT02601014 Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 Status COMPLETED Phase PHASE2
NCT02600468 Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg Status COMPLETED Phase N/A
NCT02600455 Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL Status COMPLETED Phase N/A
NCT02599649 Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) Status TERMINATED Phase PHASE2
NCT02599402 Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma Status COMPLETED Phase PHASE3
NCT02598960 An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread. Status COMPLETED Phase PHASE1/PHASE2
NCT02598466 Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa Status COMPLETED Phase N/A
NCT02596035 An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE4
NCT02593786 A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02592798 Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) Status COMPLETED Phase PHASE2
NCT02591732 A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark Status COMPLETED Phase N/A
NCT02589158 SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat Status COMPLETED Phase PHASE1
NCT02588625 A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Status WITHDRAWN Phase PHASE2
NCT02581644 Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries Status COMPLETED Phase N/A
NCT02581631 An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas Status COMPLETED Phase PHASE1/PHASE2
NCT02580474 The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure Status COMPLETED Phase PHASE4
NCT02576509 An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT02576457 Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis Status TERMINATED Phase PHASE1